Clinical Trials Logo

Hyperbaric Oxygen Therapy clinical trials

View clinical trials related to Hyperbaric Oxygen Therapy.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT05136716 Completed - Cerebral Palsy Clinical Trials

Effect of Hyperbaric Oxygen Therapy on Cerebral Palsy

Start date: September 2, 2020
Phase: N/A
Study type: Interventional

Abnormal gait is a common issue in children with CP. As a result of motor weakness and a lack of voluntary motor control. Furthermore, gait in children with cerebral palsy is characterized by a slower walking speed, a shorter stride length, and more time spent in double support. Deficits in postural control constitute a major limitation to the motor development in children with CP. The performance of static and dynamic tasks, such as sitting, standing, and walking, is limited in these children due to postural instability. Postural control deficits in CP are caused by altered sensory processing, motor impairment, and biomechanical alignment, which result in altered neuromuscular responses. HBO2 therapeutic benefits in CP are attributed to an increase in dissolved oxygen in plasma and tissue, which aids tissue regeneration, So, the purpose of this study was to investigate the long-term effects of hyperbaric oxygen therapy on spatiotemporal gait parameters and functional balance skills in children with CP.

NCT ID: NCT04358796 Completed - Clinical trials for Hyperbaric Oxygen Therapy

Measuring Cognitive Enhancement During Hyperbaric Oxygen Treatments

Start date: November 10, 2017
Phase: N/A
Study type: Interventional

The aim of the current study was to examine the effect of short-term HBOT (hyperbaric oxygen treatments) on a range of cognitive abilities. The current study examined whether there is a HBOT-related short-term cognitive improvement and, if so, what specific cognitive abilities are improved by the intervention. Participants were randomized to perform cognitive tasks in one of two chambers with two different clinical environments: (a) HBOT condition: (2 ATA (atmosphere absolute) 100% oxygen for 90 minutes). (b) Control condition: in which the chamber was not pressurized (Normobaric condition- 1 ATA for 90 minutes).

NCT ID: NCT03980210 Completed - Clinical trials for Hyperbaric Oxygen Therapy

Effect of Hyperbaric Oxygen Therapy on Microcirculation

MICROHB
Start date: June 14, 2019
Phase: N/A
Study type: Interventional

Previous studies shoes that hyperoxia alters microcirculation.The investigators hypothesize that hyperbaric may restore microcirculation integrity. This hypothesis is supported by a recent study in rabbits, but no data exists for humans. The study will expose fifteen healthy volunteers to a succession of different fraction of inspired oxygen and barometric pressure and assess microcirculatory and macrocirculatory changes via sidestream dark field videomicroscopy, near-infrared spectroscopy, Laser Doppler, transthoracic echocardiography and bio-impedancemetry at every step.

NCT ID: NCT03615755 Completed - Diabetic Foot Ulcer Clinical Trials

Short Duration Hyperbaric Oxygen Therapy to Improve HbA1c, Leukocyte, and Serum Creatinine

Start date: December 27, 2016
Phase: N/A
Study type: Interventional

The investigators want to evaluate the short duration HBOT can improve glycohemoglobin (HbA1c) levels, leukocyte count, and serum creatinine levels in patients with DFU (diabetic foot ulcer) Wagner 3-4.

NCT ID: NCT02619383 Completed - Clinical trials for Erectile Dysfunction

HBOT Application in Erectile Dysfunction

HBOTED
Start date: June 2013
Phase: Phase 1
Study type: Interventional

Recent studies have shown that hyperbaric oxygen therapy (HBOT) can induce angiogenesis and improve impaired organ function. HBOT was also recently suggested as a possible therapy for ED due to surgical injuries. However, the effect of HBOT on non-surgical related ED has not been investigated to date. The objective in this study was to assess the effect of HBOT on patients with ED by means of sexual function questionnaires and novel imaging techniques.